Natixis Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Sell |
|
|||||
|
2025
Q1 | $2.35M | Buy |
|
|||||
|
2024
Q4 | $1.3M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.56M | Sell |
|
|||||
|
2024
Q1 | $4.84M | Sell |
|
|||||
|
2023
Q4 | $5.75M | Sell |
|
|||||
|
2023
Q3 | $5.3M | Buy |
|
|||||
|
2023
Q2 | $5.18M | Sell |
|
|||||
|
2023
Q1 | $5.93M | Sell |
|
|||||
|
2022
Q4 | $6.45M | Sell |
|
|||||
|
2022
Q3 | $6.41M | Buy |
|
|||||
|
2022
Q2 | $5.67M | Buy |
|
|||||
|
2022
Q1 | $4.65M | Sell |
|
|||||
|
2021
Q4 | $5.69M | Buy |
|
|||||
|
2021
Q3 | $4.29M | Buy |
|
|||||
|
2021
Q2 | $2.52M | Buy |
|
|||||
|
2021
Q1 | $1.51M | Sell |
|
|||||
|
2020
Q4 | $4.79M | Buy |
|
|||||
|
2020
Q3 | $2.87M | Buy |
|
|||||
|
2020
Q2 | $4.13M | Buy |
|
|||||
|
2020
Q1 | $1.31M | Buy |
|
|||||
|
2019
Q4 | $1.16M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $2.53M | Sell |
|
|||||
|
2019
Q1 | $2.97M | Buy |
|
|||||
|
2018
Q4 | $2.81M | Sell |
|
|||||
|
2018
Q3 | $3.27M | Sell |
|
|||||
|
2018
Q2 | $3.28M | Buy |
|
|||||
|
2018
Q1 | $1.41M | Sell |
|
|||||
|
2017
Q4 | $1.59M | Buy |
|
|||||
|
2017
Q3 | $1.66M | Buy |
|
|||||
|
2017
Q2 | $1.39M | Buy |
|
|||||
|
2017
Q1 | $1.33M | Buy |
|
|||||
|
2016
Q4 | $1.05M | Buy |
|
|||||
|
2016
Q3 | $1.01M | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $218K | Sell |
|
|||||
|
2014
Q1 | $273K | Sell |
|
|||||
|
2013
Q4 | $663K | Buy |
|
|||||
|
2013
Q3 | $430K | Buy |
|